The impact of increasing neurological disability of multiple sclerosis on health utilities: a systematic review of the literature

10.1007/BF02999222

10.1016/j.jns.2007.01.065

Aronson KJ, 1997, Neurology, 48, 74, 10.1212/WNL.48.1.74

Schumacher GA, 1965, Ann NY Acad Sci, 22, 552, 10.1111/j.1749-6632.1965.tb20235.x

10.1080/0963828031000090506

McCabe MP, 2005, J Health Psychol, 10, 163, 10.1177/1359105305048562

10.1212/WNL.50.6.1594

10.1080/09638280010022090

Miltenburger C, 2002, Clin Neurol Neurosurg, 104, 272, 10.1016/S0303-8467(02)00051-3

Rothwell PM, 1997, Br Med J, 314, 1580, 10.1136/bmj.314.7094.1580

Drummond M, Sculpher M, Torrance G, Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford: Oxford University Press, 2005.

Furlong W, 2001, Ann Med, 33, 375, 10.3109/07853890109002092

Furlong W, Feeny D, Torrance G, Multiplicative multi-attribute utility function for the Health Utilities Index Mark 3 (HUI3) system: a technical report: McMaster University, 1998.

10.1111/j.1524-4733.2006.00144.x

Kobelt G, 2006, Eur J Health Econ, 7, S96, 10.1007/s10198-006-0380-z

Parkin D, 2000, J Neurol Neurosurg Psychiatry, 68, 144, 10.1136/jnnp.68.2.144

Forbes RB, 1999, Br Med J, 319, 1529, 10.1136/bmj.319.7224.1529

Grima DT, 2000, Multiple Sclerosis, 6, 91, 10.1177/135245850000600207

10.1186/1477-7525-6-1

10.1136/jnnp.2003.017897

Kobelt G, 2001, HEPAC Health Economics in Prevention and Care, 2, 60, 10.1007/s101980100057

Kobelt G, 2006, Eur J Health Econ, 7, 534

Berg J, 2006, Eur J Health Econ, 7, S75, 10.1007/s10198-006-0379-5

10.1046/j.1468-1331.2001.00169.x

Kobelt G, 2006, Eur J Health Econ, 7, 514

10.1007/s10198-006-0377-7

Kobelt G, 2006, Eur J Health Econ, 7, S45, 10.1007/s10198-006-0385-7

Kobelt G, 2006, Eur J Health Econ, 7, S55, 10.1007/s10198-006-0378-6

Kobelt G, 2006, Eur J Health Econ, 7, S65, 10.1007/s10198-006-0381-y

Kobelt G, 2006, Eur J Health Econ, 7, S86, 10.1007/s10198-006-0383-9

Prosser LA, 2003, Mult Scler, 9, 311, 10.1191/1352458503ms903oa

Dolan P, Gudex C, Kind P, A Social Tariff for EuroQol: Results from a UK General Population Survey. York, UK: Center for Health Economics, University of York, 1995.

McAlpine D, 1952, QJM, 21, 135

Kobelt G, 2006, Eur J Health Econ, 7, S5, 10.1007/s10198-006-0365-y

Coughlin SS, 1990, J Clin Epidemiol, 43, 87, 10.1016/0895-4356(90)90060-3

Brazier J, 2008, Pharmacoeconomics, 26, 769, 10.2165/00019053-200826090-00007

Dolan P, 1997, Soc Sci Med, 44, 1519, 10.1016/S0277-9536(96)00271-7

Gruenewald DA, 2004, Mult Scler, 10, 251, 10.1191/1352458504ms1116rr

Gold MR, Siegel JE, Russell LB, Cost Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.